Sympathomimetic drugs form a classification of medication used to manage and treat cardiovascular pathology, hypersensitivity, COPD, and glaucoma. This activity reviews the indications, action, and contraindications for sympathomimetics as valuable agents in treating and managing cardiovascular pathology (and other disorders when applicable). This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, monitoring, relevant interactions) pertinent for members of the healthcare team) in the management of patients with cardiovascular pathology and related conditions.

**Objectives:**
- Identify the mechanism of action of sympathomimetic drugs.
- Describe the adverse effect profile of sympathomimetic drugs.
- Review the appropriate monitoring needed for patients using sympathomimetic drugs.
- Explain the importance of collaboration and communication amongst the interprofessional team to ensure the appropriate use of sympathomimetics and to reduce associated complications.